Most Recent
Settlement offer not inadmissible in case against law firm, judge says
A judge has ruled that a settlement offer made in a case can be adduced into evidence in a construction company’s suit against its former lawyers, finding that the offer was not covered by without penalty privilege.
ACCC accuses online training provider of misleading consumers
The competition regulator has taken training provider Express Online Training to court for allegedly misleading consumers by promising they would only be charged for their online courses upon completion and that the courses could be finished in one day.
Firm’s fees in Boston Scientific class action OK’d, 8 months after settlement gets nod
A judge has signed off on almost $7.5 million in fees billed by the law firm behind the pelvic mesh class action against Boston Scientific, eight months after he approved the device maker's $105 million settlement.
Clive Palmer loses challenge to rejection of Gold Coast development plan
Clive Palmer has lost his bid to overturn a council decision to reject his plan for a residential development at a Gold Coast flood plain, with a judge noting that would-be residents would be subject to the “adverse odours” of a nearby sewerage treatment plant.
AMP to pay $100M to settle BOLR class action
AMP has agreed to pay $100 million to settle a class action by financial advisers over its buyer of last resort policy, after suffering a loss at trial.
United class action wants to add commission agents, join parent company
A franchise class action against United Petroleum has asked a court for leave to expand the class action to include a group of commission agents and to add the oil company's parent as a third defendant.
ASIC dodges indemnity costs for ‘unreasonable’ rejection of settlement in case against liquidator
ASIC has escaped an individual insolvency practitioner’s bid for indemnity costs in its failed case alleging illegal phoenix activity, with a judge finding the regulator did not unreasonably reject a settlement offer that would have netted it “a considerably better result” than it won at trial.
Sandoz tries again to invalidate Xarelto patents
Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and failed to revoke two Bayer patents for the drug.
KPMG asks High Court again to hear class action transfer fight
Accounting firm KPMG has asked the High Court for a second time to weigh in on the relevance of a contingency fee order made in a Victoria Supreme Court class action to its bid to transfer the case to NSW.